scholarly journals Mesenteric Lymphadenopathy in Children with Chronic Abdominal Pain - A Single Center Retrospective Case Control Study from a Tertiary Care Center in Puducherry

2021 ◽  
Vol 8 (21) ◽  
pp. 1664-1667
Author(s):  
Satyamanasa Gayatri Vinay S ◽  
Bruntha R ◽  
Sudhagar M

BACKGROUND Mesenteric lymphadenitis (MLN) is found commonly associated with children having chronic abdominal pain, but its significance is rarely mentioned in literature. Mesenteric lymphadenitis is the inflammation of the mesenteric lymph nodes that drain the gastrointestinal tract. The present study was undertaken to assess the prevalence and significance of mesenteric lymphadenopathy among children with chronic abdominal pain (CAP). METHODS This is a single center retrospective case control study conducted in the department of paediatrics of a private medical college in Puducherry. Data was obtained from the records over a period of past 24 months. Cases were defined as 5 - 15 years aged children presenting with chronic abdominal pain. Controls were defined as 5 - 15 years aged children who were subjected to abdominal ultrasonography for reasons other than abdominal pain. Records over past 24 months were studied and for uniformity of analysis, a total of 100 children aged 5 - 15 years, were included in both the groups. Data from the case records was analysed retrospectively to calculate the prevalence of mesenteric lymphadenitis in both the groups. RESULTS Chronic abdominal pain was almost equal in both sexes with a male : female ratio of 0.9 : 1. In our study, the incidence of significant MLN among children with chronic abdominal pain was 89 % [n = 89, out of 100 cases] and was 26 % among controls [n = 26, out of 100 controls]. CONCLUSIONS This study showed that MLN is one of the most common findings in children with CAP with higher incidence among cases than controls and is statistically significant. Abdominal ultrasonography is a useful tool in the evaluation of CAP to rule out organic causes. KEYWORDS Chronic Abdominal Pain (CAP), American Academy of Paediatrics (AAP), Mesenteric Lymphadenopathy [MLN], Recurrent Abdominal Pain (RAP)

2015 ◽  
Vol 24 (5) ◽  
pp. 2085-2091 ◽  
Author(s):  
Tulay Kus ◽  
Gokmen Aktas ◽  
Gokay Alpak ◽  
Mehmet Emin Kalender ◽  
Alper Sevinc ◽  
...  

2020 ◽  
Author(s):  
Ran Tian ◽  
Wei Wu ◽  
Chunyao Wang ◽  
Haiyu Pang ◽  
Zhiyu Zhang ◽  
...  

Abstract Since the outbreak of COVID-19 in China at the end of 2019, the world has experienced a large-scale epidemic caused by the SARS-CoV-2. Epidemiological and clinical course of COVID-19 patients have been reported, but there have been few analyses about the characteristics, predictive risk factors and outcomes of critical patients. In this single-center retrospective case-control study, 90 adult inpatients hospitalized at Tongji Hospital (Wuhan, China) were included. Demographic, clinical, laboratory test and treatment data were obtained and compared between critical and non-critical patients. We found that compared with non-critical patients, the critical patients had higher SOFA score and qSOFA scores. Critical patients had lower lymphocyte and platelet count, elevated D-dimer, decreased fibrinogen, and elevated high-sensitivity C-reactive protein (hsCRP) and interleukin-6(IL-6). More critical patients received treatment including antibiotics, anticoagulation, corticosteroid and oxygen therapy than non-critical ones. Multivariable regression showed higher qSOFA score and elevation of IL-6 were related to critical patients. Antibiotic usage and anticoagulation were associated with decreased in-hospital mortality. And critical grouping contributed greatly to in-hospital death. Critical COVID-19 patients have a more severe clinical cours. qSOFA score and elevation of IL-6 are risk factors for critical condition. Non-critical grouping, positive antibiotic application and anticoagulation may be beneficial for patient survival.


Sign in / Sign up

Export Citation Format

Share Document